Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer

NCT03497702 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

114

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Cancer
Invasive Breast Cancer

Interventions

DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Docetaxel
DRUG: Letrozole
DRUG: leuprorelin

Sponsor

National Cancer Center, Korea